About this trial
"Huede" AI Aided AKI Prediction Software, Acura AKI, uses machine learning algorithms to predict the risk of AKI within the next 24 hours and provide a ranking of feature importance. By using Acura AKI, physicians can assess the risk of AKI, focusing on high-risk patients to provide care decisions. This study will be conducted in a prospective randomized clinical trial in adult ICUs, implementing the Acura AKI system for predicting AKI. The study aims to determine whether early prediction and intervention using the Acura AKI system can improve the outcomes of critically ill patients with adverse kidney conditions. The study endpoint is to evaluate the cost-effectiveness of using Acura AKI, including the incidence of AKI, dialysis rates, mortality rates, length of hospital stay, and treatment costs.
Eligibility criteria
Qualifiers
Over 20 years old
Admitted to adult ICU
Hospital stay of more than 30 hours
Disqualifiers
Known to have acute kidney injury at enrollment
Currently undergoing hemodialysis treatment
No available blood or urine test data
Pregnant women
Trial design
Treatments tested in this trial
- Acura AKI